| Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT) (NCT05761054) | Azienda Ospedaliero-Universitaria Careggi | 2022-07-19 |
| FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) (NCT05432193) | POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company | 2022-07-13 |
| Phase II Study of TAEST16001 in Soft Tissue Sarcoma (NCT05549921) | Sun Yat-sen University | 2022-07-08 |
| B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) (NCT04897321) | St. Jude Children's Research Hospital | 2022-07-06 |
| Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma (NCT05526417) | Mayo Clinic | 2022-06-08 |
| PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS (NCT06413095) | Presage Biosciences | 2022-06-01 |
| A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma (NCT05301764) | Lyvgen Biopharma Holdings Limited | 2022-05-25 |
| A Study of HFB301001 in Adult Patients With Advanced Solid Tumors (NCT05229601) | HiFiBiO Therapeutics | 2022-04-20 |
| Hypofractionated vs Conventional Fractionated RT in Soft Tissue Sarcomas (NCT05109494) | University of Wisconsin, Madison | 2022-04-06 |
| A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors (NCT05355753) | C4 Therapeutics, Inc. | 2022-03-25 |
| A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma (NCT05121350) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-03-01 |
| Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma (NCT05116800) | Brown University | 2022-03-01 |
| INPWT on Wound Complications & Clinical Outcomes After Lower Extremity Sarcoma Surgery Preop Radiation Therapy Patients (NCT03175718) | Dr. J. Werier | 2022-02-01 |
| Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy (NCT05057195) | Blokhin's Russian Cancer Research Center | 2022-01-10 |
| Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma. (NCT05189483) | Henan Cancer Hospital | 2022-01-01 |
| Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01) (NCT05224934) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-01-01 |
| HIFU Ablation of Soft Tissue Sarcoma (NCT05111964) | Oxford University Hospitals NHS Trust | 2021-12-10 |
| HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma (NCT04995003) | Baylor College of Medicine | 2021-12-07 |
| Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types (NCT05000294) | University of Florida | 2021-12-07 |
| Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance (NCT06202599) | Peking University People's Hospital | 2021-11-25 |
| Fruquintinib in the Treatment of Soft Tissue Sarcoma (NCT05142631) | Fudan University | 2021-11-21 |
| Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma (NCT04383119) | Italian Sarcoma Group | 2021-10-29 |
| tTF-NGR Randomized Study - STS (NCT05597917) | Universität Münster | 2021-10-26 |
| Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients (NCT05051059) | Universitaire Ziekenhuizen KU Leuven | 2021-10-01 |
| A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas (NCT04906876) | Brown University | 2021-09-01 |
| The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients (NCT05741944) | Leiden University Medical Center | 2021-08-24 |
| Adriamycin and Ifosfamide Combined With Sintilimab (NCT04589754) | Sun Yat-sen University | 2021-07-26 |
| A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours (NCT04969835) | Avacta Life Sciences Ltd | 2021-07-16 |
| Neoadjuvant Irradiation of Extremity Soft Tissue Sarcoma With Ions (NCT04946357) | University Hospital Heidelberg | 2021-06-21 |
| Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas (NCT05131386) | Grupo Espanol de Investigacion en Sarcomas | 2021-05-28 |
| Exercise and Soft Tissue Sarcoma (NCT04921917) | Duke University | 2021-04-30 |
| Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma (NCT05747521) | Henan Cancer Hospital | 2021-04-29 |
| Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma (NCT04776525) | Oslo University Hospital | 2021-04-27 |
| Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group (NCT03967834) | Institut Claudius Regaud | 2021-04-26 |
| PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine (NCT05697198) | Labcorp Corporation of America Holdings, Inc | 2021-04-19 |
| A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients (NCT04811196) | University Health Network, Toronto | 2021-03-29 |
| Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors (NCT04579757) | Hutchmed | 2021-03-05 |
| A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors (NCT04725331) | Transgene | 2021-02-25 |
| Predictive Models of Treatment Responses and Survival Outcomes in Patients With Soft Tissue Sarcoma (NCT05171413) | West China Hospital | 2021-01-01 |
| Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot) (NCT04634227) | University of Iowa | 2020-11-24 |
| Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma (NCT04910126) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2020-11-12 |
| Toripalimab Combined With CAV/IE Regimen (NCT04589741) | Sun Yat-sen University | 2020-10-23 |
| Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma (NCT04307277) | Institut Claudius Regaud | 2020-10-09 |
| Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma (NCT04577014) | Memorial Sloan Kettering Cancer Center | 2020-09-29 |
| Prehabilitation Soft-Tissue Sarcoma of Lower Limb (NCT04518488) | McGill University | 2020-09-15 |
| TVEC and Preop Radiation for Sarcoma (8 ml Dose) (NCT04599062) | John Rieth | 2020-09-10 |
| Efficacy and Safety of L19TNF in Previously Treated Patients with Advanced Stage or Metastatic Soft-tissue Sarcoma (NCT04733183) | Philogen S.p.A. | 2020-08-28 |
| Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities (NCT04037527) | Wake Forest University Health Sciences | 2020-08-18 |
| B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT04483778) | Seattle Children's Hospital | 2020-07-13 |
| Identification of Surgical Management of Lymph Node Basins and Surgical Practice Patterns Among Sarcoma Surgeons (NCT04553744) | M.D. Anderson Cancer Center | 2020-06-22 |
| TAEST16001 in the Treatment of Soft Tissue Sarcoma (NCT04318964) | Sun Yat-sen University | 2020-03-19 |
| Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs (NCT04288375) | Memorial Sloan Kettering Cancer Center | 2020-02-26 |
| Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery (NCT02923778) | National Cancer Institute (NCI) | 2019-12-31 |
| A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers. (NCT04166006) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2019-12-12 |
| Surveillance AFter Extremity Tumor surgerY (NCT03944798) | McMaster University | 2019-11-19 |
| Rehabilitation and Quality of Life Assessment for Soft Tissue Sarcoma Treated With Radiotherapy and Surgery (NCT03916796) | Washington University School of Medicine | 2019-10-31 |
| Molecular Profiling of Advanced Soft-tissue Sarcomas (NCT03784014) | Institut National de la Santé Et de la Recherche Médicale, France | 2019-10-19 |
| Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors (NCT04165330) | Sarcoma Oncology Research Center, LLC | 2019-10-17 |
| A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors (NCT03997968) | Cyteir Therapeutics, Inc. | 2019-10-09 |
| Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration (NCT04040205) | Medical College of Wisconsin | 2019-10-07 |
| Ipilimumab + Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma (NCT04118166) | Kristen Ganjoo | 2019-10-01 |
| Dose Finding Study of L19TNF and Doxorubicin in Patients With STS (NCT04032964) | Philogen S.p.A. | 2019-09-05 |
| Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma (NCT04012827) | Sun Yat-sen University | 2019-08-20 |
| Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK (NCT04181970) | Grupo Espanol de Investigacion en Sarcomas | 2019-06-30 |
| High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas (NCT03508726) | Mohammed Milhem | 2019-06-27 |
| EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT03618381) | Seattle Children's Hospital | 2019-06-18 |
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors (NCT03899792) | Eli Lilly and Company | 2019-06-13 |
| Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma (NCT04126811) | Tianjin Medical University Cancer Institute and Hospital | 2019-06-01 |
| A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors (NCT03960060) | Shanghai PerHum Therapeutics Co., Ltd. | 2019-05-16 |
| Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma (NCT03890068) | Sun Yat-sen University | 2019-04-11 |
| APX005M and Doxorubicin in Advanced Sarcoma (NCT03719430) | Alexander Z. Wei, MD | 2019-03-20 |
| FMISO PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue Sarcomas (NCT03730077) | University of Pennsylvania | 2019-02-01 |
| Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer (NCT04239443) | Hunan Cancer Hospital | 2019-01-30 |
| Circulating Tumor DNA in Soft Tissue Sarcoma (NCT03818412) | University Health Network, Toronto | 2019-01-17 |
| Liposomal Bupivacaine (Exparel) in Sarcomas (NCT03867188) | Wake Forest University Health Sciences | 2019-01-14 |
| Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy (NCT03792542) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2019-01-01 |
| LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04) (NCT03725605) | Lytix Biopharma AS | 2018-12-28 |
| Incisional Negative Pressure Wound Therapy for Resection of Soft Tissue Tumors (NCT03900078) | Ruhr University of Bochum | 2018-12-01 |
| Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma (NCT03602833) | Royal Marsden NHS Foundation Trust | 2018-11-05 |
| NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma (NCT03524898) | Swiss Cancer Institute | 2018-10-02 |
| US-Guided Biopsy in the Diagnosis of Musculoskeletal Soft-Tissue Tumors (NCT03452644) | Istituto Ortopedico Rizzoli | 2018-09-20 |
| Gemcitabine Plus Ascorbate for Sarcoma in Adults (NCT03468075) | Mohammed Milhem, MBBS | 2018-07-11 |
| Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma (NCT03217266) | National Cancer Institute (NCI) | 2018-06-20 |
| Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 (NCT02890758) | Brenda Cooper, MD | 2018-05-22 |
| Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma (NCT03514381) | Institut Claudius Regaud | 2018-05-18 |
| ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer (NCT03449901) | Washington University School of Medicine | 2018-05-09 |
| A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (NCT03475953) | Institut Bergonié | 2018-05-04 |
| FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CW (NCT03913806) | University Medical Center Groningen | 2018-05-01 |
| LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas (NCT03449108) | M.D. Anderson Cancer Center | 2018-04-27 |
| Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma (NCT03338959) | Fred Hutchinson Cancer Center | 2018-03-28 |
| RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions. (NCT03375437) | Centre Leon Berard | 2018-02-15 |
| PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies (NCT03365791) | Novartis Pharmaceuticals | 2018-01-24 |
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma (NCT02982486) | Assaf-Harofeh Medical Center | 2017-12-01 |
| A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma (NCT04650984) | Philogen S.p.A. | 2017-11-29 |
| Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) (NCT03220035) | National Cancer Institute (NCI) | 2017-11-08 |
| A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma (NCT03283696) | Eli Lilly and Company | 2017-10-18 |
| Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia (NCT03007771) | Washington University School of Medicine | 2017-09-30 |
| A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS) (NCT02910895) | The Netherlands Cancer Institute | 2017-09-09 |
| Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) (NCT03016819) | Advenchen Laboratories, LLC | 2017-08-15 |
| Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) (NCT03114527) | Fox Chase Cancer Center | 2017-08-08 |